Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Data Loss Prevention and Security Governance
The Rising Risk in Modern Digital WorkplacesEmployees share files across Teams, SharePoint, email, and external platforms every day. AI tools like Copilot add another layer of complexity. Sensitive…
|
AI Governance in the Digital Workplace: Policies for Copilot and Agents in 2026
The AI Governance Challenge in 2026Copilot and autonomous AI agents are rolling out rapidly across enterprises. They promise huge productivity gains in the digital workplace. Yet most organizations…
|
Digital Workplace Governance
The Control Crisis in Digital WorkplacesShadow IT, permission sprawl, and configuration drift create growing risks. Employees adopt new tools rapidly. Compliance teams struggle to keep pace. The…
|
7 R’s Decision Matrix
7 R’s Decision MatrixThe Cost of Over-EngineeringEnterprise modernization projects rarely fail because organizations lack ambition. Most fail because they apply the wrong level of ambition to the…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
